Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
VanEck Oil Services ETF
OIH
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
US Stock MarketDetailed Quotes
Zenas BioPharma (ZBIO)
- 18.190
- -0.300-1.62%
Close Apr 24 16:00 ET
- 18.190
- 0.0000.00%
Post 20:01 ET
1.13BMarket Cap-2.16P/E (TTM)
18.635High17.630Low564.71KVolume18.400Open18.490Prev Close10.26MTurnover1.42%Turnover RatioLossP/E (Static)62.37MShares44.60052wk High4.69P/B724.72MFloat Cap8.51052wk Low--Dividend TTM39.84MShs Float44.600Historical High--Div Yield TTM5.44%Range %5.830Historical Low18.170Avg Price1Lot Size
Zenas BioPharma (ZBIO) Key Financial Indicators
ZBIO Earnings per Share (EPS)
According to the latest financial report of Zenas BioPharma, the latest earnings per share (TTM) for the company is -4.54. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
ZBIO Free Cash Flow (FCF)
Interested in knowing about Zenas BioPharma's free cash flow? The latest report shows it as -82.41M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
ZBIO Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Zenas BioPharma shows that the company's current ratio is 5.61, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
ZBIO Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Zenas BioPharma, the quick ratio is 5.48, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ZBIO Return on Equity (ROE)
Want to learn more about the financial health of Zenas BioPharma? The latest ROE figure is -109.65%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ZBIO Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Zenas BioPharma, the total asset return on investment (ROA) is -68.15%.
Currency: USD
Quarterly
Loading...
ZBIO Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Zenas BioPharma's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
ZBIO Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Zenas BioPharma, the net profit margin is -335.73%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm